Ana Weil
Acting Instructor
Department of Medicine, Division of Allergy & Infectious Diseases

Faculty Information

Biography

Dr. Ana Weil studies the relationship between the gut microbiome and immune responses to enteric diseases. Using molecular, genomic and immunologic methods, she investigates how the gut microbiome influences susceptibility to enteric infections, modulation of immune responses by the gut microbiome, and pathogen-gut microbe interactions at the mucosal surface.

She works with several US-based collaborators and the International Centre for Diarrhoeal Disease Research, Bangladesh.

 

Education & Training: 
MPH
Johns Hopkins University School of Public Health
Baltimore MD
2004
MD
Tufts University School of Medicine
Medford MA
2010
Residency
Massachusetts General Hospital
Bostom MA
2013
Fellowship
Massachusetts General Hospital
Boston MA
2015
Honors: 
Fulbright Scholar, Malawi
2001
Fogarty/NIH Clinical Scholar, International Center for Diarrheal Disease Research, Bangaldesh
2007
William Damesheck Research Award, Tufts Medical School
2010
Edward H. Kass Award for Excellence in Research, Infectious Disease Society of America
2012
Edward H. Kass Award for Clinical Excellence, Massachusetts Infectious Disease Society
2014
Chief Resident, Department of Medicine, Massachusetts General Hospital
2015-2016
ID Week Abstract Committee Choice Award, ID Week Program Committee
2015
Morton N. Swartz Professional Development Award, Division of Infectious Diseases, MGH
2018
Contact
Phone: 
(206) 616-0779
Mailing Address: 

Center for Emerging & Re-Emerging Infectious E771

Research & Clinical Interests
Research Interests: 
  • microbiome science
  • immune responses to vaccination
  • host-pathogen interactions
Clinical Interests: 

solid organ transplant infectious diseases

Publications
Publications: 

Azman AS, Lessler J, Luquero FJ, Bhuiyan TR, Khan AI, Chowdhury F, Kabir A, Gurwith M, Weil AA, Harris JB, Calderwood SB, Ryan ET, Qadri F, Leung DT. Estimating cholera incidence with cross-sectional serology. Science translational medicine. 2019; 11(480).
• PubMed Abstract

Ritter AS, Chowdhury F, Franke MF, Becker RL, Bhuiyan TR, Khan AI, Saha NC, Ryan ET, Calderwood SB, LaRocque RC, Harris JB, Qadri F, Weil AA. Vibriocidal Titer and Protection From Cholera in Children, Open Forum Infectious Diseases. 2019 April; 6(4):ofz057.
• PubMed Abstract

Midani FS*, Weil AA*, Chowdhury F, Begum YA, Khan AI, Debela MD, Durand HK, Reese AT, Nimmagadda SN, Silverman JD, Ellis CN, Ryan ET, Calderwood SB, Harris JB, Qadri F, David LA, LaRocque RC. Human Gut Microbiota Predicts Susceptibility to Vibrio cholerae Infection. The Journal of Infectious Diseases. 2018; 218(4):645-653. * Co-first authors.
• PubMed Abstract

David LA, Weil AA, Ryan ET, Calderwood SB, Harris JB, Chowdhury F, Begum Y, Qadri F, LaRocque RC, Turnbaugh PJ. Gut Microbial Succession Follows Acute Secretory Diarrhea in Humans. MBio. 2015 May 19; 6(3):e00381-15.
• PubMed Abstract

Weil AA, Begum Y, Chowdhury F, Khan AI, Leung DT, LaRocque RC, Charles RC, Ryan ET, Calderwood SB, Qadri F, Harris JB. Bacterial shedding in household contacts of cholera patients in Dhaka, Bangladesh. Am Journal Trop Med Hyg. 2014 Oct; 91(4)738-42.
• PubMed Abstract